Change - Announcement of Cessation::Cessation of Director of Corporate Affairs & General Manager - Yee Chia Hsing

Issuer & Securities

Issuer/ Manager
IX BIOPHARMA LTD.
Securities
IX BIOPHARMA LTD. - SG1BD9000009 - 42C
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
15-Jul-2022 17:21:16
Status
New
Announcement Sub Title
Cessation of Director of Corporate Affairs & General Manager - Yee Chia Hsing
Announcement Reference
SG220715OTHR1XS1
Submitted By (Co./ Ind. Name)
Gwendolin Lee Soo Fern
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Resignation of Mr. Yee Chia Hsing as Director of Corporate Affairs and General Manager of Entity Health Ltd.


This announcement has been prepared by iX Biopharma Ltd. (the Company) and its contents have been reviewed by the Company s Sponsor, UOB Kay Hian Private Limited (the Sponsor), for compliance with the relevant rules of the Singapore Exchange Securities Trading Limited (the SGX-ST) Listing Manual Section B: Rules of Catalist.

This announcement has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of this announcement, including the accuracy, completeness or correctness of any of the information, statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Mr. Lance Tan, Senior Vice President, at 8 Anthony Road, #01-01, Singapore 229957, telephone: (65) 6590 6881.

Additional Details

Name Of Person
Yee Chia Hsing
Age
51
Is effective date of cessation known?
Yes
If yes, please provide the date
29/07/2022
Detailed Reason (s) for cessation
Mr. Yee Chia Hsing has tendered his resignation with the Company to pursue other career opportunities. To provide continuity, his responsibilities will be taken over by the Company's Chief Commercial Officer, Ms. Eva Tan. Based on its enquiries, the Sponsor is satisfied that, save as disclosed in this announcement, there are no other material reasons for Mr. Yee's cessation as Director of Corporate Affairs and General Manager of Entity Health Ltd.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
01/03/2021
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
2
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
1
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Director of Corporate Affairs and General Manager of Entity Health Ltd.
Role and responsibilities
Promote corporate profiling of the Company among various stakeholders, manage Entity Health brand, and assist CEO on various matters as may be needed.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
None
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
8,000 ordinary shares in iX Biopharma Ltd
Past (for the last 5 years)
Independent Director, Ezion Holding Limited
Present
Lead Independent Director, First Sponsor Group Limited